News Daily News Acute AF Can Recur: Manage and Monitor Long-term, Says AHA Michael O'Riordan March 16, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Opinion Editor's Corner ACC 2023 What’s Going to Be Hot at ACC/WCC 2023? Shelley Wood February 27, 2023
News Daily News LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis Todd Neale February 24, 2023
News Conference News ISC 2023 Does All AF After Stroke Warrant Anticoagulation? Experts Debate Todd Neale February 17, 2023
Presentation Miami Valves 2023 SCD Prevention: Highlights of 35 years´ Research Collaboration Between Miami and Oulu Cardiac Research Teams Presenter: Heikki V. Huikuri February 03, 2023
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes Yael L. Maxwell December 06, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News Slight Risk of Interstitial Lung Disease Seen With Certain DOACs Todd Neale November 23, 2022
News Conference News AHA 2022 Etripamil Nasal Spray in Paroxysmal SVT Speeds Conversion to Sinus Rhythm: RAPID Shelley Wood November 07, 2022
News Conference News AHA 2022 Botulinum Toxin Injections No Help for Postoperative AF: NOVA Yael L. Maxwell November 07, 2022
News Conference News AHA 2022 First-line Ablation Reduces AF Progression, Boosts Quality of Life Todd Neale November 07, 2022
News Daily News Apixaban Again Linked to Less Bleeding in AF Patients Michael O'Riordan October 31, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News RAPID: Positive Top-line Results for Etripamil Nasal Spray in Paroxysmal SVT Todd Neale October 17, 2022